Evidence map›Paper›PMID 41034732›Full record

ArticleBMC bioinformatics2025

MysteryMaster: scraping the bottom of the barrel of barcoded Oxford nanopore reads.

Abdolrahman Khezri, Sverre Branders, Anurag Basavaraj Bellankimath, Jawad Ali, Crystal Chapagain, Fatemeh Asadi, Manfred G Grabherr, Rafi Ahmad

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abdolrahman KhezriDepartment of Biotechnology, University of Inland Norway, Holsetgata 22, 2317, Hamar, Norway.
Sverre BrandersDepartment of Biotechnology, University of Inland Norway, Holsetgata 22, 2317, Hamar, Norway.
Anurag Basavaraj BellankimathDepartment of Biotechnology, University of Inland Norway, Holsetgata 22, 2317, Hamar, Norway.
Jawad AliDepartment of Biotechnology, University of Inland Norway, Holsetgata 22, 2317, Hamar, Norway.
Crystal ChapagainDepartment of Biotechnology, University of Inland Norway, Holsetgata 22, 2317, Hamar, Norway.
Fatemeh AsadiDepartment of Biotechnology, University of Inland Norway, Holsetgata 22, 2317, Hamar, Norway.
Manfred G GrabherrDepartment of Biotechnology, University of Inland Norway, Holsetgata 22, 2317, Hamar, Norway.
Rafi AhmadDepartment of Biotechnology, University of Inland Norway, Holsetgata 22, 2317, Hamar, Norway. rafi.ahmad@inn.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe high error rate associated with Oxford Nanopore sequencing technology adversely affects demultiplexing. To improve demultiplexing and reduce unclassified reads from nanopore sequencing data, we developed MysteryMaster, a demultiplexer that utilizes the optimal sequence aligner, Cola.

resultsWhen compared to Oxford Nanopore´s Dorado and Guppy demultiplexing tools across three datasets of 37 diverse samples with established ground truth, we found that MysteryMaster accurately identifies a similar or greater percentage of reads among the different basecalling models: Fast, HAC, and SUP. MysteryMaster performs slightly better than the other tools on data that was basecalled using the Fast basecalled model, while its performance in HAC and SUP data is similar to Dorado's. MysteryMaster has a false positive rate of just 0.41% with default settings.

conclusionsWhile MysteryMaster can function as a standalone demultiplexer tool, the sequential application of Dorado and MysteryMaster produced the best overall performance.

Indexed as

NanoporesNanopore SequencingSequence Analysis, DNASoftwareAlgorithmsHigh-Throughput Nucleotide SequencingHumansSequence AlignmentBarcodingDemultiplexingDoradoGuppyMysterymasterOxford nanopore sequencingUnclassified reads

Identifiers

PMID41034732
PMCPMC12487470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.